title: Decreased activation of carcinogens in the liver of carcinogen-resistant rats.
abstract: We have developed a new strain of rats (resistant rat) which exhibit resistance against the carcinogenic action of several carcinogenic compounds. In the present study, we compared the ability of resistant rat liver to activate 3'-methyl-4-dimethylaminoazobenzene and 2-acetylaminofluorene to highly reactive metabolites, which can covalently bind to DNA, with that of carcinogen-sensitive parent strain rats (sensitive rat), using in vitro DNA binding assay. The covalent binding of these carcinogens to calf thymus DNA, catalyzed by the hepatic 9000 x g supernatant fraction from resistant rats pretreated with 3-methylcholanthrene, was about one-half of that catalyzed by the 9000 x g supernatant from sensitive rats which had received the same treatment. These results suggest that the ability of resistant rat liver to activate the carcinogens decreases compared to sensitive rat liver. Further experiments revealed that this decreased activation of the carcinogens in resistant rat livers is due to a low inducibility of 3-methylcholanthrene-inducible forms of cytochrome P-450 mRNA. The hepatic cytosolic Ah receptor concentrations in resistant rats were shown to be significantly lower than those of sensitive rats. Scatchard plot analysis demonstrated, however, that there is no significant difference between the affinity of Ah receptors for 2,3,7,8-tetrachlorodibenzo-p-dioxin in these two strains. These data implicate that the hepatic Ah receptor level may be an important factor in determining carcinogen sensitivity in rats.
authors.affiliation: Department of Oncology, Osaka University Medical School, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Yano
authors.forename: T
authors.initials: T
authors.lastname: Higashi
authors.forename: S
authors.initials: S
authors.lastname: Kano
authors.forename: N
authors.initials: N
authors.lastname: Tateishi
authors.forename: Y
authors.initials: Y
authors.lastname: Kido
authors.forename: T
authors.initials: T
authors.lastname: Mori
authors.forename: K
authors.initials: K
authors.lastname: Higashi
authors.forename: Y
authors.initials: Y
authors.lastname: Sakamoto
mesh_terms: D015073:2-Acetylaminofluorene / Q000378:metabolism*; D000818:Animals; D015152:Blotting, Northern; D003577:Cytochrome P-450 Enzyme System / Q000032:analysis; D004247:DNA / Q000378:metabolism; D015342:DNA Probes; D004351:Drug Resistance; D008099:Liver / Q000378:metabolism*; D008749:Methyldimethylaminoazobenzene / Q000378:metabolism*; D008862:Microsomes, Liver / Q000378:metabolism; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D018336:Receptors, Aryl Hydrocarbon; D011955:Receptors, Drug / Q000032:analysis; D004124:p-Dimethylaminoazobenzene / Q000031:analogs & derivatives*
chemical_list: D015342:DNA Probes; D012333:RNA, Messenger; D018336:Receptors, Aryl Hydrocarbon; D011955:Receptors, Drug; D008749:Methyldimethylaminoazobenzene; D004247:DNA; D003577:Cytochrome P-450 Enzyme System; D015073:2-Acetylaminofluorene; D004124:p-Dimethylaminoazobenzene